Covid-19

Showing NaN - NaN of 92

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Patients Given Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine

Recruiting
  • Influenza, Human
  • COVID-19
  • Comirnaty
  • Quadrivalent Influenza Vaccine
  • New York, New York
    Pfizer
May 11, 2023

COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196
  • +3 more
  • Tucson, Arizona
  • +106 more
Mar 24, 2023

COVID-19 Trial in United States (drug, biological, other)

Active, not recruiting
  • COVID-19
  • Birmingham, Alabama
  • +21 more
Feb 2, 2023

COVID-19 Trial in New York (SMARTest mobile app for COVID-19 self-testing)

Recruiting
  • COVID-19
  • SMARTest mobile app for COVID-19 self-testing
  • New York, New York
    ICAP Harlem Prevention Center
Jan 25, 2023

NIH RECOVER Tissue Pathology: Understanding Long-Term Impact of

Recruiting
  • COVID-19
  • SARS CoV 2 Infection
    • New York, New York
      NYU Langone Health
    Jan 25, 2023

    COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

    Recruiting
    • COVID-19
    • +2 more
    • Birmingham, Alabama
    • +68 more
    Jan 24, 2023

    Covid-19, Substance Use, Opioid Use Trial in New York (Chain-referral, Credible Messenger)

    Completed
    • Covid-19
    • +2 more
    • Chain-referral
    • Credible Messenger
    • New York, New York
      New York State Psychiatric Institute
    Jan 19, 2023

    COVID-19 Trial in Worldwide (AZD7442, Placebo)

    Completed
    • COVID-19
    • Jasper, Alabama
    • +102 more
    Jan 14, 2023

    Inpatient COVID-19 Treatments

    Active, not recruiting
    • COVID-19
    • Initiation of IL6Ri (tocilizumab or sarilumab) versus JAKi (baricitinib or tofacitinib) added to systemic corticosteroids of interest (CSI)
    • New York, New York
      Aetion, Inc.
    Jan 12, 2023

    COVID-19 Trial in United States (other, drug, biological)

    Completed
    • COVID-19
    • Placebo
    • +2 more
    • Tucson, Arizona
    • +31 more
    Nov 23, 2022

    COVID-19 Trial in New York (Hydroxychloroquine (HCQ))

    Completed
    • COVID-19
    • Hydroxychloroquine (HCQ)
    • New York, New York
      NYU Langone Health
    Dec 12, 2022

    COVID-19 Trial in Worldwide (ADG20, Placebo)

    Terminated
    • COVID-19
    • Birmingham, Alabama
    • +94 more
    Nov 22, 2022

    SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19

    Completed
    • SARS-CoV Infection
    • +3 more
    • Moderna COVID-19 Vaccine
    • +2 more
    • Tucson, Arizona
    • +28 more
    Sep 19, 2022

    SARS-CoV2 Infection, COVID-19 Trial in Long Beach, Miami Lakes, New York (IMM-BCP-01, Placebo)

    Recruiting
    • SARS-CoV2 Infection
    • COVID-19
    • Long Beach, California
    • +2 more
    Aug 11, 2022

    COVID-19 Trial in United States (Ad26.COV2.S, BNT162b2, mRNA-1273)

    Recruiting
    • COVID-19
    • Ad26.COV2.S
    • +4 more
    • Atlanta, Georgia
    • +11 more
    Aug 11, 2022

    COVID-19 Trial in Worldwide (nirmatrelvir, ritonavir)

    Recruiting
    • COVID-19
    • Birmingham, Alabama
    • +94 more
    Aug 2, 2022

    COVID-19, Long COVID, Pulmonary Fibrosis Trial in Aurora, New York, Houston (BIO 300 Oral Suspension, Placebo)

    Recruiting
    • COVID-19
    • +4 more
    • BIO 300 Oral Suspension
    • Placebo
    • Aurora, Colorado
    • +3 more
    Aug 1, 2022

    COVID-19 Quantitative Antibody Titers & Booster Vaccinations

    Completed
    • COVID-19
    • +2 more
    • Observational
    • New York, New York
      AHD Manhattan Midtown HCC
    Jul 26, 2022

    COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)

    Completed
    • COVID-19
    • Lenzilumab
    • +2 more
    • Birmingham, Alabama
    • +55 more
    Jul 21, 2022

    COVID-19 Trial in United States (Danicopan, Placebo, Remdesivir)

    Completed
    • COVID-19
    • Birmingham, Alabama
    • +38 more
    Jul 21, 2022

    COVID-19 Trial in Worldwide (PF-07321332, Ritonavir, Placebo)

    Active, not recruiting
    • COVID-19
    • Pelham, Alabama
    • +336 more
    Jul 21, 2022

    2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in United States (Famotidine,

    Terminated
    • 2019 Novel Coronavirus Disease
    • +11 more
    • Newport Beach, California
    • +14 more
    Jul 20, 2022

    CU-COMMITS: COVID-Care in Black and Latino Communities and

    Recruiting
    • COVID-19
    • SARS CoV 2 Infection
    • Survey
    • +2 more
    • New York, New York
      Columbia University Irving Medical Center
    Jul 19, 2022

    COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)

    Active, not recruiting
    • COVID-19
    • SARS-CoV-2
    • AZD1222
    • Placebo
    • Phoenix, Arizona
    • +83 more
    Jul 13, 2022

    Transmission of COVID-19 in Households of SARS-CoV-2 Index Cases

    Recruiting
    • COVID-19
    • +2 more
      • New York, New York
        Columbia University Irving Medical Center
      Jul 19, 2022